Atazanavir Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 150 mg, 200 mg, 300 mg
Reference Brands: Reyataz®(EU & US)
Category:
Anti Viral
Atazanavir Capsules (150–300 mg), sold under brands like Reyataz® and Atavir®, are protease inhibitors for HIV-1 treatment. Widely used in combination therapy, they’re available for bulk procurement on PharmaB2B platforms from WHO-GMP suppliers—ideal for tenders, NGOs, and HIV programs.
Atazanavir is available in Capsules
and strengths such as 150 mg, 200 mg, 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Atazanavir is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Atazanavir can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Atazanavir Capsules, marketed globally under brands like Reyataz®, Atavir®, and Atazor®, are essential protease inhibitors used in combination antiretroviral therapy (cART) for HIV-1 treatment. Available in 150 mg, 200 mg, and 300 mg strengths, Atazanavir is often co-administered with Ritonavir to boost its effectiveness. With WHO and USFDA endorsements, PharmaB2B platforms enable global sourcing from GMP-certified manufacturers for bulk procurement, tenders, and public health supply chains. This once-daily dosing option is well-tolerated and vital in global HIV management programs. Partner with trusted suppliers to ensure quality and cost-effective access to key antiretroviral medicines.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing